Treatment of severe psoriasis and psoriatic arthritis with adalimumab in an HIV-positive patient

Journal of Drugs in Dermatology

Volumn 13, Issue 7, 2014, Pages 869-871

  Lindsey, Scott F ^a   Weiss, Jonathan ^a   Lee, Eric S ^a   Romanelli, Paolo ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CALCIPOTRIOL; CYCLOSPORIN; EFAVIRENZ; EMTRICITABINE; ETRAVIRINE; ETRETIN; METHOTREXATE; RALTEGRAVIR; TENOFOVIR; TRIAMCINOLONE; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIVIRAL THERAPY; ARTICLE; BODY SURFACE; CASE REPORT; CD4 LYMPHOCYTE COUNT; DISEASE SEVERITY; DRUG EFFECT; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; MEDICATION COMPLIANCE; PHOTOTHERAPY; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS LOAD; ANTAGONISTS AND INHIBITORS; ARTHRITIS, PSORIATIC; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PATHOLOGY; PSORIASIS; SEVERITY OF ILLNESS INDEX;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904119764     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377-385.
2. Fife DJ, Waller JM, Jeffes EW, Koo JY. Unraveling the paradoxes of HlV-associated psoriasis: A review of T-cell subsets and cytokine profiles. Dermatol Online J. 2007;13(2):4.
3. Menon K, Van Voorhees AS, Bebo BF, Jr et al. Psoriasis in patients with HIV infection: From the medical board of the national psoriasis foundation. J Am Acad Dermatol. 2010;62(2):291-299.
4. Mallon E, Bunker CB. HIV-associated psoriasis. AIDS Patient Care STDS. 2000;14(5):239-246. (Pubitemid 30321653)
5. Montazeri A, Kanitakis J, Bazex J. Psoriasis and HIV infection. Int J Dermatol. 1996;35(7):475-479. (Pubitemid 26233397)
6. Menter A, Tyring SK, Gordon K et al. Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. J Am Acad Dermatol. 2008;58(1):106-115. (Pubitemid 350298146)
7. Cepeda EJ, Williams FM, Ishimori ML, Weisman MH, Reveille JD. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease. Ann Rheum Dis. 2008;67(5):710-712. (Pubitemid 351571938)
8. Calabrese LH, Zein N, Vassilopoulos D. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: Hepatitis C, hepatitis B, and HIV infection. Ann Rheum Dis. 2004;63 Suppl 2:ii18-ii24. (Pubitemid 39424653)
9. Ting PT, Koo JY. Use of etanercept in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients. Int J Dermatol. 2006;45(6):689-692. (Pubitemid 44056670)
10. Sellam J, Bouvard B, Masson C et al. Use of infliximab to treat psoriatic arthritis in HIV-positive patients. Joint Bone Spine. 2007;74(2):197-200. (Pubitemid 46603012)
11. Bartke U, Venten I, Kreuter A, Gubbay S, Altmeyer P. Brockmeyer NH. Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab. Br J Dermatol. 2004;150(4):784-786. (Pubitemid 38586243)
12. Linardaki G, Katsarou O, loannidou P et al. Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection. J Rheumatol. 2007;34(6):1353-1355. (Pubitemid 46898121)
13. Aboulafia DM, Bundow D, Wilske K, Ochs UI. Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis. Mayo Clin Proc. 2000:75(10):1093-1098.
14. Mikhail M, Weinberg JM, Smith BL. Successful treatment with etanercept of von zumbusch pustular psoriasis in a patient with human immunodeficiency virus. Arch Dermatol. 2008;144(4):453-456. (Pubitemid 351581101)
15. Lee ES, Heller MM, Kamangar F, Park KK, Koo JY. Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: A case study. J Drugs Dermatol. 2012;11(3):413-414.
16. Rustin MH. Long-term safety of biologies in the treatment of moderate-to-severe plaque psoriasis: Review of current data. Br J Dermatol. 2012; 167 Suppl 3:3-11.